NYSE: MPWMedical Properties Trust Inc Stock
$4.14+0.00 (+0%)
Updated Dec 6, 2024
MPW Price
$4.14
Fair Value Price
N/A
Market Cap
$2.48B
52 Week Low
$2.92
52 Week High
$6.55
P/E
-0.93x
P/B
0.46x
P/S
5.48x
PEG
N/A
Dividend Yield
9.18%
Revenue
$641.32M
Earnings
-$2.66B
Gross Margin
25%
Operating Margin
-343.69%
Profit Margin
-415%
Debt to Equity
1.8
Operating Cash Flow
$304M
Beta
1.1
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
MPW Overview
Medical Properties Trust Inc (MPT) is a Real Estate Investment Trust (REIT) that net-leases healthcare facilities including community and inpatient rehabilitation hospitals, behavioral health facilities, long-term acute care hospitals, general acute care hospitals, single-discipline facilities, medical office buildings, and surgical facilities. MPT was founded in 2003 and is headquartered in Birmingham, AL.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MPW's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
D
Value
C
Growth
C
Momentum
F
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Healthcare Facility REIT
Industry Rating
D
MPW
Ranked#15 of 16
Ranked#15 of 16
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $9.83 | B | |
| $37.73 | B | |
| $39.25 | C |
Be the first to know about important MPW news, forecast changes, insider trades & much more!
MPW News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MPW scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MPW is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MPW is good value based on its book value relative to its share price (0.46x), compared to the US REIT - Healthcare Facilities industry average (2.13x)
P/B vs Industry Valuation
MPW is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more MPW due diligence checks available for Premium users.
Valuation
MPW price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.93x
Industry
-12.81x
Market
29.86x
MPW price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.46x
Industry
2.13x
MPW is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MPW's financial health
Profit margin
Revenue
$225.8M
Net Income
-$801.2M
Profit Margin
-354.8%
MPW's Earnings (EBIT) of -$2.20B... subscribe to Premium to read more.
Interest Coverage Financials
MPW's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$15.2B
Liabilities
$9.8B
Debt to equity
1.8
MPW's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MPW's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$59.2M
Investing
$143.8M
Financing
-$548.1M
MPW's operating cash flow ($304.21M)... subscribe to Premium to read more.
Debt Coverage Financials
MPW vs Healthcare Facility REIT Stocks
Medical Properties Trust Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.